Drug intelligence / Profile preview

TauroSept

Development stage
Unknown
Lead developer
Geistlich Pharma
Modality
Small Molecules
Administration
Catheter Lock
01

Overview

TauroSept is an antimicrobial catheter lock solution developed by Geistlich Pharma AG. It contains 2% taurolidine, a synthetic antimicrobial agent derived from the amino acid taurine. Classified as a medical device, TauroSept is used for the prevention of catheter-related bloodstream infections (CRBSIs) and the maintenance of device patency in central vascular access devices (CVADs). It is administered via local/intraluminal instillation into the catheter between treatments. Taurolidine exerts broad-spectrum activity against gram-positive and gram-negative bacteria, as well as yeasts and molds, by reacting with components of the microbial cell wall and toxins, which minimizes the risk of developing bacterial resistance.

Brand names
TauroSeptGeistlich TauroSept
Other names
taurolidine 2% catheter lock solution
02

Targets

LPS (Lipopolysaccharide)

Beyond the preview

Go deeper on TauroSept.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TauroSept.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call